FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

632 letters match. Newest first.

  1. Advanced Cosmetic Research Laboratories Inc.

    FDA cited Advanced Cosmetic Research Laboratories for manufacturing-quality violations at its Chatsworth drug plant and an unapproved 5% lidocaine cream.

    High risk
  2. Beijing Xinggu Lvsan Technology Co., Ltd. Formerly known as Beijing Lvsan Technology Co., Ltd.

    FDA cites Beijing Xinggu Lvsan for manufacturing-rule failures and unapproved, misbranded hand sanitizers.

    High risk
  3. American Cleaning Solutions

    FDA warned American Cleaning Solutions after a 2022 inspection found hand sanitizer made with inadequate cleaning, unvalidated processes, and substituted ethanol.

    High risk
  4. Eksa Mills S.A. de C.V.

    FDA cited Eksa Mills for CGMP violations, including shared-equipment contamination risks, after an April 2022 inspection of its Mexican drug facility.

    High risk
  5. Legacy Pharmaceutical Packaging LLC

    Legacy Pharmaceutical Packaging, a drug repackager, was cited for CGMP violations and insanitary conditions after foreign tablets and floor-picked tablets were found.

    High risk
  6. Sterling Pharmaceutical Services, LLC

    Sterling Pharmaceutical Services, LLC made sterile ophthalmic drugs with manufacturing violations and marketed unapproved new drugs.

    High risk
  7. System Kosmetik Produktionsgesellschaft fur kosmetische Gmbh

    German OTC drug maker System Kosmetik was cited for manufacturing quality violations, including missing process and cleaning validation.

    High risk
  8. Zhejiang Tianyu Pharmaceutical Co., Ltd.

    Zhejiang Tianyu Pharmaceutical made active pharmaceutical ingredients (API) with current good manufacturing practice (CGMP) deviations in impurity investigations and equipment cleaning.

    High risk
  9. Sanitizer Supply LLC

    FDA warns Sanitizer Supply LLC that its hand sanitizer wipes and sanitizers lacked required potency and microbial testing before release.

    High risk
  10. Virgin Scent Inc. dba Artnaturals

    FDA warns Artnaturals after hand sanitizer tests found benzene and acetaldehyde impurities and inspection found CGMP failures.

    High risk
  11. Episciences Inc.

    FDA warns Episciences Inc. that its Boise, Idaho plant made OTC drugs without adequate batch testing, process validation and failure investigations.

    High risk
  12. Green Wave Analytical, LLC

    FDA warned Green Wave Analytical, a contract drug testing lab, over quality violations and its denied inspection access.

    High risk
  13. Gordon Laboratories Inc.

    FDA: Gordon Laboratories' artnaturals hand sanitizer held benzene and acetaldehyde impurities, and CGMP failures let them happen.

    High risk
  14. Cangene BioPharma, LLC dba Emergent BioSolutions

    FDA cites Emergent BioSolutions Baltimore plant for CGMP violations after metal particulates and poor aseptic technique in sterile drugs.

    High risk
  15. Verde Cosmetic Labs LLC

    FDA warned Verde Cosmetic Labs after an inspection found inadequate CGMP controls for OTC topical drugs, including cleaning and water system failures.

    High risk
  16. DSP Skin Care LLC

    FDA cites DSP Skin Care for manufacturing failures and unapproved, misbranded Hongosan antifungal drugs.

    High risk
  17. Jose Miguel Gutierrez Salas

    FDA says hand sanitizer declared made by Jose Miguel Gutierrez Salas had methanol, not ethanol, and firm was not FDA-registered.

    High risk
  18. Jost Chemical Co.

    Jost Chemical Co. made active drug ingredients under CGMP deviations, including mold contamination and inadequate investigations.

    High risk
  19. Custom Research Labs Inc.

    FDA warned Custom Research Labs Inc. about manufacturing-practice violations and unapproved, misbranded OTC drugs, including hand sanitizers and topical analgesics.

    High risk
  20. Bi-Coastal Pharma International

    FDA warned Bi-Coastal Pharma International about adulterated drugs due to poor complaint handling, quality-unit oversight, batch release, and training.

    High risk
  21. Bioiberica, SAU

    FDA warned Bioiberica over unvalidated rework and missing stability testing of API batches at its Spain plant.

    High risk
  22. Genlabs Corporation

    FDA warns Genlabs Corporation of Chino, California, that its OTC hand soaps are adulterated and misbranded after finding serious CGMP failures.

    High risk
  23. DDI Multinacional S.A. de C.V.

    DDI Multinacional hand sanitizers labeled 70% ethanol contained up to 60% methanol, leading to adulteration and import alert.

    High risk
  24. Noticias Mexico Hoy Grupo Multimedia, S.A. de C.V.

    Noticias Mexico Hoy Grupo Multimedia's hand sanitizer labeled as ethanol was found to contain methanol.

    High risk
  25. Mirfeel Korea Co., Ltd.

    Mirfeel Korea's hand sanitizer contained benzene and had testing failures; FDA also says food-pouch packaging misbranded.

    High risk
  26. Industrias Cklass S. de R.L. de C.V.

    FDA found Industrias Cklass hand sanitizer labeled 70% ethanol contained 19% ethanol and 48% methanol and was refused U.S. admission.

    High risk
  27. Fagron Group B.V.

    FDA warns Fagron over cleaning and cross-contamination failures in active pharmaceutical ingredient repackaging.

    High risk
  28. Monarch PCM, LLC

    Monarch PCM, LLC made unapproved skin drugs and broke manufacturing rules, with microbial contamination and weak investigations.

    High risk
  29. Glicerinas Industriales, S.A. de C.V.

    Glicerinas Industriales refused a pre-announced FDA inspection; FDA calls its glycerin drugs adulterated and placed firm on Import Alert 66-79.

    High risk
  30. Hybrid Pharma, LLC

    FDA warned outsourcing facility Hybrid Pharma of Deerfield Beach, Florida, that sterile compounding violations made its drugs adulterated and unapproved.

    High risk
  31. Aire-Master of America, Inc.

    FDA cites Aire-Master of America for CGMP failures and unapproved, misbranded hand sanitizers made at its Missouri plant.

    High risk
  32. Colorful Products Corporation

    FDA warned Colorful Products Corporation about serious current good manufacturing practice (CGMP) failures for its over-the-counter topical drugs and hand sanitizers.

    High risk
  33. Specialty Process Labs LLC

    FDA warned Specialty Process Labs about manufacturing quality failures for thyroid USP active ingredient, including unvalidated processes and data control gaps.

    High risk
  34. David Cosmetic Co., Ltd.

    FDA lab testing found benzene, a cancer-causing impurity, at about 6 ppm in David Cosmetic's CALA hand sanitizer, making it adulterated.

    High risk
  35. Brigham and Women’s Hospital Inc.

    Brigham and Women’s Hospital PET drug facility had water leaks and fungal contamination in aseptic areas, FDA says.

    High risk
  36. Miami University Department of Chemistry and Biochemistry

    Miami University contract testing lab falsified heparin API test data and lacked CGMP controls.

    High risk
  37. Froggy’s Fog LLC

    FDA warns Froggy’s Fog that its OTC hand sanitizer was made under inadequate CGMP and mislabeled for alcohol strength.

    High risk
  38. The W.S. Badger Company, Inc.

    FDA warned W.S. Badger over repeat manufacturing-quality failures in OTC drug products, including sunscreen process, cleaning, test-method, and OOS investigation problems.

    High risk
  39. Guangzhou Zhongkebaishi Health Industry Co., Ltd.

    Guangzhou Zhongkebaishi's Hand Sanitizer Gel, labeled 75% ethanol, tested at 51% and was refused US import.

    High risk
  40. Fresh Farms LLC

    FDA warned Fresh Farms LLC about manufacturing violations in OTC hand sanitizer, including untested ethanol and missing batch records.

    High risk
  41. Cetylite Industries, Inc.

    FDA warned Cetylite Industries over CGMP violations at its Pennsauken, NJ facility, including unvalidated testing and inadequate OOS investigations for topical anesthetics.

    High risk
  42. Vitae Enim Vitae Scientific Inc.

    FDA warned Vitae Enim Vitae Scientific of sterile drug CGMP violations and contamination-control failures after a 2021 inspection, leading to a recall.

    High risk
  43. Clinical Resolution Laboratory Inc.

    FDA warned Clinical Resolution Laboratory in Brea, CA, about CGMP failures and unapproved OTC drugs.

    High risk
  44. Vi-Jon, LLC

    FDA cited Vi-Jon for manufacturing-rule violations after finding microbial water contamination, leaks, weak investigations, and data-integrity failures in OTC drugs and cosmetics.

    High risk
  45. Ultra Seal Corporation

    FDA warns Ultra Seal and ULTRAtab over manufacturing quality failures in over-the-counter drug cleaning, testing, and release.

    High risk
  46. Generitech Corporation

    FDA warned Generitech Corporation of Fresno, California over CGMP failures in its topical drug manufacturing and unapproved hydroquinone skin bleaching creams.

    High risk
  47. Yusef Manufacturing Laboratories, LLC

    FDA warned Yusef Manufacturing Laboratories over serious CGMP violations in its OTC drugs and hand sanitizers, including untested ethanol.

    High risk
  48. NDAL Mfg Inc.

    NDAL Mfg's honey nasal sprays had manufacturing-rule violations, microbial contamination, and lacked FDA approval as new drugs.

    High risk
  49. Agropharma Laboratories, Inc.

    FDA cited Agropharma Laboratories in Salinas, Puerto Rico, for serious manufacturing violations affecting its OTC antiseptics and hand sanitizers.

    High risk
  50. Dr Retter Ec Wladyslaw Retter

    FDA warns Dr Retter Ec Wladyslaw Retter over manufacturing failures for homeopathic drug cream.

    High risk